 Jeffrey Kaplan
Concepts (335)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biofilms | 31 | 2025 | 244 | 8.030 |
Why?
| | Staphylococcus epidermidis | 13 | 2025 | 75 | 3.320 |
Why?
| | Aggregatibacter actinomycetemcomitans | 15 | 2024 | 20 | 2.810 |
Why?
| | Glycoside Hydrolases | 9 | 2025 | 33 | 2.330 |
Why?
| | Bacterial Proteins | 17 | 2025 | 836 | 2.150 |
Why?
| | Anti-Bacterial Agents | 15 | 2025 | 1705 | 2.070 |
Why?
| | Polysaccharides, Bacterial | 11 | 2015 | 67 | 1.930 |
Why?
| | Staphylococcus aureus | 7 | 2018 | 434 | 1.740 |
Why?
| | Bacterial Adhesion | 14 | 2018 | 92 | 1.570 |
Why?
| | Actinobacillus pleuropneumoniae | 5 | 2013 | 5 | 1.480 |
Why?
| | DNA, Bacterial | 7 | 2024 | 321 | 1.340 |
Why?
| | Benzoyl Peroxide | 1 | 2025 | 1 | 0.960 |
Why?
| | Propionibacteriaceae | 1 | 2025 | 2 | 0.960 |
Why?
| | Propionibacterium acnes | 1 | 2025 | 10 | 0.950 |
Why?
| | Microbial Sensitivity Tests | 8 | 2025 | 348 | 0.940 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 3 | 2024 | 220 | 0.900 |
Why?
| | Micrococcal Nuclease | 1 | 2024 | 22 | 0.890 |
Why?
| | Prosthesis-Related Infections | 4 | 2011 | 75 | 0.800 |
Why?
| | Adhesins, Bacterial | 6 | 2010 | 40 | 0.790 |
Why?
| | Actinobacillus Infections | 5 | 2008 | 5 | 0.770 |
Why?
| | Kingella kingae | 2 | 2012 | 8 | 0.750 |
Why?
| | Extracellular Space | 2 | 2012 | 120 | 0.720 |
Why?
| | Amoxicillin | 2 | 2024 | 30 | 0.720 |
Why?
| | Povidone-Iodine | 2 | 2018 | 12 | 0.690 |
Why?
| | Deoxyribonuclease I | 4 | 2018 | 38 | 0.680 |
Why?
| | Acetylglucosamine | 4 | 2008 | 10 | 0.650 |
Why?
| | Staphylococcal Skin Infections | 1 | 2018 | 35 | 0.590 |
Why?
| | Cetylpyridinium | 4 | 2009 | 6 | 0.530 |
Why?
| | beta-Lactams | 2 | 2016 | 28 | 0.520 |
Why?
| | Virulence Factors | 3 | 2024 | 157 | 0.480 |
Why?
| | Pasteurellaceae | 3 | 2010 | 3 | 0.450 |
Why?
| | Genome, Bacterial | 2 | 2012 | 134 | 0.430 |
Why?
| | Exotoxins | 3 | 2008 | 15 | 0.420 |
Why?
| | Molecular Sequence Data | 12 | 2012 | 2835 | 0.420 |
Why?
| | Bacterial Capsules | 1 | 2013 | 28 | 0.420 |
Why?
| | Neisseriaceae Infections | 1 | 2012 | 5 | 0.390 |
Why?
| | Arthritis, Infectious | 1 | 2012 | 59 | 0.370 |
Why?
| | Drug Resistance, Bacterial | 4 | 2018 | 175 | 0.360 |
Why?
| | Pancreatic Neoplasms | 4 | 2024 | 880 | 0.350 |
Why?
| | Pasteurellaceae Infections | 2 | 2024 | 2 | 0.350 |
Why?
| | Recombination, Genetic | 1 | 2011 | 190 | 0.350 |
Why?
| | Extracellular Matrix | 2 | 2014 | 506 | 0.350 |
Why?
| | Enzyme Therapy | 1 | 2009 | 4 | 0.330 |
Why?
| | Mouth | 2 | 2015 | 84 | 0.310 |
Why?
| | beta-Glucans | 1 | 2008 | 27 | 0.310 |
Why?
| | Down-Regulation | 1 | 2011 | 636 | 0.300 |
Why?
| | Disinfectants | 1 | 2009 | 35 | 0.300 |
Why?
| | Haemophilus influenzae | 1 | 2009 | 64 | 0.300 |
Why?
| | Mouth Mucosa | 2 | 2007 | 88 | 0.300 |
Why?
| | Adenocarcinoma | 3 | 2024 | 893 | 0.290 |
Why?
| | Polysaccharides | 1 | 2008 | 86 | 0.290 |
Why?
| | Genes, Bacterial | 2 | 2004 | 157 | 0.280 |
Why?
| | Galactans | 1 | 2007 | 4 | 0.280 |
Why?
| | Drug Resistance | 1 | 2007 | 165 | 0.260 |
Why?
| | Aggressive Periodontitis | 2 | 2003 | 3 | 0.250 |
Why?
| | Swine Diseases | 1 | 2005 | 8 | 0.240 |
Why?
| | Acne Vulgaris | 1 | 2025 | 27 | 0.230 |
Why?
| | Humans | 38 | 2025 | 129626 | 0.230 |
Why?
| | Drug Synergism | 1 | 2025 | 370 | 0.220 |
Why?
| | Bacteria | 2 | 2012 | 814 | 0.220 |
Why?
| | Animals | 17 | 2024 | 35391 | 0.220 |
Why?
| | Acetylglucosaminidase | 1 | 2003 | 5 | 0.210 |
Why?
| | Neisseria | 1 | 2002 | 2 | 0.200 |
Why?
| | Bacteria, Anaerobic | 1 | 2002 | 22 | 0.200 |
Why?
| | Sequence Analysis, DNA | 4 | 2009 | 778 | 0.190 |
Why?
| | Bacterial Physiological Phenomena | 2 | 2014 | 58 | 0.190 |
Why?
| | Recombinant Proteins | 4 | 2018 | 1308 | 0.190 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 2021 | 66 | 0.180 |
Why?
| | Barrett Esophagus | 1 | 2023 | 148 | 0.180 |
Why?
| | Polymerase Chain Reaction | 5 | 2008 | 1035 | 0.180 |
Why?
| | Gastroesophageal Reflux | 1 | 2023 | 232 | 0.170 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2021 | 155 | 0.170 |
Why?
| | Osteopontin | 1 | 2020 | 31 | 0.170 |
Why?
| | Macrophages | 1 | 2008 | 1488 | 0.170 |
Why?
| | Chemokine CXCL10 | 1 | 2020 | 35 | 0.170 |
Why?
| | Microfluidics | 2 | 2010 | 52 | 0.170 |
Why?
| | Polystyrenes | 3 | 2004 | 37 | 0.160 |
Why?
| | Esophageal Neoplasms | 1 | 2023 | 297 | 0.160 |
Why?
| | Microfluidic Analytical Techniques | 2 | 2010 | 72 | 0.150 |
Why?
| | Sus scrofa | 1 | 2018 | 46 | 0.150 |
Why?
| | Species Specificity | 3 | 2011 | 574 | 0.150 |
Why?
| | Cystadenoma, Serous | 1 | 2018 | 18 | 0.140 |
Why?
| | Weight Gain | 1 | 2021 | 509 | 0.140 |
Why?
| | Adipose Tissue | 1 | 2021 | 591 | 0.140 |
Why?
| | Liver | 2 | 2020 | 1842 | 0.140 |
Why?
| | Base Sequence | 4 | 2012 | 2147 | 0.140 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2019 | 272 | 0.140 |
Why?
| | Pancreatic Cyst | 1 | 2018 | 52 | 0.140 |
Why?
| | Epithelial Cells | 3 | 2010 | 1075 | 0.140 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2020 | 260 | 0.140 |
Why?
| | Biopsy | 2 | 2018 | 1088 | 0.130 |
Why?
| | Neuroendocrine Tumors | 1 | 2018 | 99 | 0.130 |
Why?
| | Intestinal Pseudo-Obstruction | 1 | 2015 | 9 | 0.120 |
Why?
| | Mutagenesis, Insertional | 3 | 2008 | 65 | 0.120 |
Why?
| | Escherichia coli | 3 | 2010 | 767 | 0.120 |
Why?
| | Myositis | 1 | 2015 | 51 | 0.120 |
Why?
| | Nausea | 1 | 2015 | 111 | 0.120 |
Why?
| | Staphylococcal Infections | 2 | 2012 | 389 | 0.120 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2007 | 539 | 0.120 |
Why?
| | Acinetobacter baumannii | 1 | 2014 | 18 | 0.120 |
Why?
| | Air | 1 | 2014 | 36 | 0.120 |
Why?
| | Muscle, Smooth | 1 | 2015 | 161 | 0.110 |
Why?
| | DNA Transposable Elements | 3 | 2008 | 119 | 0.110 |
Why?
| | Liver Neoplasms | 1 | 2019 | 639 | 0.110 |
Why?
| | Periodontal Diseases | 1 | 2015 | 61 | 0.110 |
Why?
| | Bone Resorption | 1 | 2015 | 80 | 0.110 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2014 | 84 | 0.110 |
Why?
| | Abdominal Pain | 1 | 2015 | 143 | 0.110 |
Why?
| | Anilides | 1 | 2014 | 70 | 0.110 |
Why?
| | Immunoglobulins | 1 | 2014 | 161 | 0.110 |
Why?
| | Plankton | 1 | 2014 | 5 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2014 | 74 | 0.110 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2011 | 2011 | 0.110 |
Why?
| | Gastrointestinal Diseases | 1 | 2015 | 198 | 0.110 |
Why?
| | Surface Properties | 4 | 2012 | 397 | 0.100 |
Why?
| | Molecular Weight | 1 | 2013 | 329 | 0.100 |
Why?
| | Pancreas | 1 | 2014 | 303 | 0.100 |
Why?
| | Coated Materials, Biocompatible | 1 | 2012 | 59 | 0.100 |
Why?
| | Cell Survival | 3 | 2012 | 1076 | 0.090 |
Why?
| | Disease Models, Animal | 3 | 2018 | 4078 | 0.090 |
Why?
| | Tobramycin | 1 | 2011 | 51 | 0.090 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2014 | 269 | 0.090 |
Why?
| | Cell Communication | 1 | 2013 | 301 | 0.090 |
Why?
| | Biomarkers, Tumor | 2 | 2014 | 1164 | 0.090 |
Why?
| | Genetic Complementation Test | 2 | 2008 | 63 | 0.090 |
Why?
| | Pyridines | 1 | 2014 | 478 | 0.090 |
Why?
| | Orthopedic Equipment | 1 | 2010 | 5 | 0.090 |
Why?
| | Culture Media | 3 | 2010 | 162 | 0.090 |
Why?
| | Treatment Failure | 1 | 2011 | 339 | 0.090 |
Why?
| | Focal Nodular Hyperplasia | 1 | 2010 | 3 | 0.080 |
Why?
| | Escherichia coli Proteins | 1 | 2011 | 179 | 0.080 |
Why?
| | Fungi | 1 | 2011 | 136 | 0.080 |
Why?
| | Bacterial Outer Membrane Proteins | 2 | 2007 | 59 | 0.080 |
Why?
| | Female | 12 | 2024 | 68734 | 0.080 |
Why?
| | Titanium | 1 | 2010 | 76 | 0.080 |
Why?
| | DNA Primers | 2 | 2007 | 511 | 0.080 |
Why?
| | Osteoblasts | 1 | 2010 | 116 | 0.080 |
Why?
| | Mutation | 5 | 2009 | 3717 | 0.080 |
Why?
| | Prostheses and Implants | 1 | 2010 | 135 | 0.080 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 2009 | 22 | 0.080 |
Why?
| | Sodium Hypochlorite | 1 | 2009 | 4 | 0.080 |
Why?
| | Convection | 1 | 2008 | 6 | 0.080 |
Why?
| | Enzymes | 1 | 2009 | 65 | 0.080 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2011 | 323 | 0.080 |
Why?
| | Chlorhexidine | 1 | 2009 | 24 | 0.080 |
Why?
| | Azo Compounds | 1 | 2008 | 26 | 0.080 |
Why?
| | Colony Count, Microbial | 1 | 2009 | 117 | 0.080 |
Why?
| | Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 2008 | 4 | 0.080 |
Why?
| | Diffusion | 1 | 2008 | 116 | 0.080 |
Why?
| | Phylogeny | 2 | 2002 | 850 | 0.070 |
Why?
| | Obesity | 1 | 2021 | 2882 | 0.070 |
Why?
| | Caenorhabditis elegans | 1 | 2011 | 296 | 0.070 |
Why?
| | Pancreatectomy | 2 | 2024 | 242 | 0.070 |
Why?
| | Periodontitis | 2 | 2006 | 49 | 0.070 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 2007 | 11 | 0.070 |
Why?
| | Congo Red | 1 | 2007 | 9 | 0.070 |
Why?
| | Gene Order | 1 | 2007 | 26 | 0.070 |
Why?
| | Tritium | 1 | 2007 | 75 | 0.070 |
Why?
| | Detergents | 1 | 2007 | 44 | 0.070 |
Why?
| | Middle Aged | 8 | 2024 | 31136 | 0.070 |
Why?
| | Chromosomes, Bacterial | 1 | 2007 | 8 | 0.070 |
Why?
| | Ampicillin | 1 | 2007 | 14 | 0.070 |
Why?
| | Glycosyltransferases | 1 | 2007 | 13 | 0.070 |
Why?
| | Genetic Variation | 2 | 2002 | 939 | 0.070 |
Why?
| | Male | 11 | 2024 | 63670 | 0.070 |
Why?
| | Colorectal Neoplasms | 1 | 2014 | 749 | 0.070 |
Why?
| | Glycogen Storage Disease Type IV | 1 | 2006 | 4 | 0.070 |
Why?
| | 1,4-alpha-Glucan Branching Enzyme | 1 | 2006 | 4 | 0.070 |
Why?
| | Amino Acid Sequence | 3 | 2008 | 2057 | 0.070 |
Why?
| | Cohort Studies | 3 | 2024 | 5426 | 0.060 |
Why?
| | Hydrogels | 2 | 2012 | 630 | 0.060 |
Why?
| | Pleuropneumonia | 1 | 2005 | 1 | 0.060 |
Why?
| | Cell Line, Tumor | 2 | 2014 | 3186 | 0.060 |
Why?
| | Gene Deletion | 1 | 2007 | 382 | 0.060 |
Why?
| | Aged | 6 | 2024 | 22061 | 0.060 |
Why?
| | Mice | 5 | 2021 | 16961 | 0.060 |
Why?
| | Prenatal Diagnosis | 1 | 2006 | 194 | 0.060 |
Why?
| | Carbohydrate Metabolism | 1 | 2004 | 62 | 0.060 |
Why?
| | Primates | 1 | 2005 | 120 | 0.060 |
Why?
| | Lactoferrin | 1 | 2003 | 28 | 0.050 |
Why?
| | Polyethylene Glycols | 1 | 2008 | 589 | 0.050 |
Why?
| | Catheterization | 1 | 2004 | 175 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 2046 | 0.050 |
Why?
| | Metaplasia | 1 | 2023 | 57 | 0.050 |
Why?
| | O Antigens | 1 | 2003 | 8 | 0.050 |
Why?
| | Agar | 1 | 2002 | 12 | 0.050 |
Why?
| | Bacteriological Techniques | 1 | 2003 | 69 | 0.050 |
Why?
| | Swine | 1 | 2005 | 764 | 0.050 |
Why?
| | Promoter Regions, Genetic | 2 | 2009 | 1207 | 0.050 |
Why?
| | Microscopy, Electron | 1 | 2003 | 426 | 0.050 |
Why?
| | Serotyping | 1 | 2002 | 28 | 0.050 |
Why?
| | Liver Transplantation | 1 | 2010 | 833 | 0.050 |
Why?
| | DNA, Ribosomal | 1 | 2002 | 83 | 0.050 |
Why?
| | Mice, Obese | 1 | 2021 | 61 | 0.050 |
Why?
| | Neoplasm Staging | 2 | 2016 | 1282 | 0.050 |
Why?
| | Esophagoscopy | 1 | 2023 | 198 | 0.050 |
Why?
| | Neoadjuvant Therapy | 1 | 2024 | 379 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2003 | 367 | 0.050 |
Why?
| | Aromatase Inhibitors | 1 | 2021 | 51 | 0.050 |
Why?
| | Bacterial Toxins | 1 | 2002 | 104 | 0.050 |
Why?
| | Thinness | 1 | 2021 | 89 | 0.040 |
Why?
| | Phenotype | 2 | 2010 | 3075 | 0.040 |
Why?
| | Adult | 6 | 2020 | 35599 | 0.040 |
Why?
| | Tamoxifen | 1 | 2021 | 197 | 0.040 |
Why?
| | Kinetics | 1 | 2004 | 1645 | 0.040 |
Why?
| | Models, Biological | 1 | 2007 | 1724 | 0.040 |
Why?
| | Coculture Techniques | 2 | 2010 | 223 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2002 | 524 | 0.040 |
Why?
| | Temperature | 1 | 2002 | 637 | 0.040 |
Why?
| | Transcription, Genetic | 2 | 2020 | 1418 | 0.040 |
Why?
| | ROC Curve | 1 | 2020 | 503 | 0.040 |
Why?
| | Infant | 1 | 2012 | 8995 | 0.040 |
Why?
| | Postoperative Complications | 1 | 2010 | 2477 | 0.040 |
Why?
| | Cyst Fluid | 1 | 2018 | 25 | 0.040 |
Why?
| | Carcinoembryonic Antigen | 1 | 2018 | 39 | 0.040 |
Why?
| | Cell Movement | 1 | 2002 | 948 | 0.040 |
Why?
| | Surgical Instruments | 1 | 2018 | 51 | 0.030 |
Why?
| | Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2018 | 55 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2023 | 958 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2019 | 7052 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 949 | 0.030 |
Why?
| | Endosonography | 1 | 2018 | 141 | 0.030 |
Why?
| | Matched-Pair Analysis | 1 | 2016 | 40 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2024 | 10219 | 0.030 |
Why?
| | Giant Cells | 1 | 2016 | 23 | 0.030 |
Why?
| | Binding Sites | 2 | 2010 | 1248 | 0.030 |
Why?
| | Cell Line | 2 | 2012 | 2784 | 0.030 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2016 | 208 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 1560 | 0.030 |
Why?
| | CD3 Complex | 1 | 2015 | 102 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 1843 | 0.030 |
Why?
| | Monosaccharides | 1 | 2014 | 12 | 0.030 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2016 | 377 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 2 | 2015 | 2395 | 0.030 |
Why?
| | HCT116 Cells | 1 | 2014 | 78 | 0.030 |
Why?
| | Immunoenzyme Techniques | 1 | 2014 | 212 | 0.030 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 81 | 0.030 |
Why?
| | Intestine, Small | 1 | 2015 | 151 | 0.030 |
Why?
| | Transcriptome | 1 | 2020 | 876 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2018 | 869 | 0.030 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2014 | 183 | 0.030 |
Why?
| | Lymphocytes | 1 | 2015 | 378 | 0.030 |
Why?
| | Colon | 1 | 2015 | 254 | 0.030 |
Why?
| | Microscopy | 1 | 2014 | 141 | 0.030 |
Why?
| | Radiography | 1 | 2015 | 797 | 0.030 |
Why?
| | Angiogenesis Inhibitors | 1 | 2014 | 219 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2014 | 943 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2020 | 3378 | 0.030 |
Why?
| | Disease Progression | 1 | 2020 | 2627 | 0.030 |
Why?
| | Mice, Nude | 1 | 2014 | 682 | 0.030 |
Why?
| | Neovascularization, Pathologic | 1 | 2014 | 296 | 0.020 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2014 | 361 | 0.020 |
Why?
| | Polymethacrylic Acids | 1 | 2012 | 62 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2014 | 432 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2019 | 1501 | 0.020 |
Why?
| | Gene Expression Profiling | 2 | 2009 | 1687 | 0.020 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2014 | 808 | 0.020 |
Why?
| | Rats | 2 | 2015 | 5483 | 0.020 |
Why?
| | Survival Rate | 1 | 2016 | 1872 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2015 | 1432 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 5455 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2542 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2014 | 1159 | 0.020 |
Why?
| | Propidium | 1 | 2010 | 8 | 0.020 |
Why?
| | 3T3 Cells | 1 | 2010 | 154 | 0.020 |
Why?
| | Cell Shape | 1 | 2010 | 54 | 0.020 |
Why?
| | Alloys | 1 | 2010 | 34 | 0.020 |
Why?
| | Siphoviridae | 1 | 2009 | 2 | 0.020 |
Why?
| | Artificial Gene Fusion | 1 | 2009 | 3 | 0.020 |
Why?
| | Bacteriophage T7 | 1 | 2009 | 5 | 0.020 |
Why?
| | Plasmids | 1 | 2010 | 359 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2010 | 452 | 0.020 |
Why?
| | Protein Hydrolysates | 1 | 2008 | 6 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2014 | 1336 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2012 | 877 | 0.020 |
Why?
| | Time Factors | 2 | 2010 | 6555 | 0.020 |
Why?
| | Nucleotides | 1 | 2009 | 122 | 0.020 |
Why?
| | Caseins | 1 | 2008 | 19 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2009 | 265 | 0.020 |
Why?
| | Buffers | 1 | 2008 | 56 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2010 | 399 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2008 | 196 | 0.020 |
Why?
| | Orthopedics | 1 | 2010 | 136 | 0.020 |
Why?
| | Adolescent | 2 | 2010 | 20412 | 0.020 |
Why?
| | Rifampin | 1 | 2008 | 83 | 0.020 |
Why?
| | Microscopy, Atomic Force | 1 | 2008 | 118 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2009 | 388 | 0.020 |
Why?
| | Sodium Chloride | 1 | 2008 | 137 | 0.020 |
Why?
| | Cercopithecidae | 1 | 2007 | 8 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2008 | 332 | 0.020 |
Why?
| | Phosphates | 1 | 2008 | 179 | 0.020 |
Why?
| | Child | 2 | 2010 | 20884 | 0.020 |
Why?
| | Cyclic AMP | 1 | 2008 | 238 | 0.020 |
Why?
| | Hydrolysis | 1 | 2007 | 186 | 0.020 |
Why?
| | Abortion, Eugenic | 1 | 2006 | 3 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2007 | 372 | 0.020 |
Why?
| | Drug Interactions | 1 | 2008 | 395 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2007 | 371 | 0.020 |
Why?
| | Imaging, Three-Dimensional | 1 | 2010 | 528 | 0.020 |
Why?
| | Knee Prosthesis | 1 | 2006 | 18 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2007 | 361 | 0.020 |
Why?
| | Hemolysis | 1 | 2008 | 199 | 0.020 |
Why?
| | Hip Prosthesis | 1 | 2006 | 37 | 0.020 |
Why?
| | Equipment Design | 1 | 2008 | 514 | 0.020 |
Why?
| | Prognosis | 1 | 2014 | 3774 | 0.020 |
Why?
| | Tissue Engineering | 1 | 2010 | 388 | 0.020 |
Why?
| | Genome Components | 1 | 2006 | 2 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2007 | 541 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2006 | 300 | 0.020 |
Why?
| | Protein Transport | 1 | 2007 | 429 | 0.020 |
Why?
| | Fimbriae, Bacterial | 1 | 2006 | 28 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2012 | 1891 | 0.010 |
Why?
| | Membrane Transport Proteins | 1 | 2006 | 149 | 0.010 |
Why?
| | Calcium | 1 | 2010 | 1212 | 0.010 |
Why?
| | Computer Simulation | 1 | 2008 | 939 | 0.010 |
Why?
| | Spodoptera | 1 | 2003 | 37 | 0.010 |
Why?
| | Genetic Testing | 1 | 2006 | 430 | 0.010 |
Why?
| | Alveolar Bone Loss | 1 | 2003 | 9 | 0.010 |
Why?
| | Maxilla | 1 | 2003 | 33 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2010 | 2373 | 0.010 |
Why?
| | Cloning, Molecular | 1 | 2003 | 525 | 0.010 |
Why?
| | Models, Molecular | 1 | 2007 | 1491 | 0.010 |
Why?
| | Adenosine Triphosphatases | 1 | 2003 | 161 | 0.010 |
Why?
| | Virulence | 1 | 2003 | 255 | 0.010 |
Why?
| | Iron | 1 | 2003 | 282 | 0.010 |
Why?
| | Signal Transduction | 1 | 2014 | 4931 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 2003 | 637 | 0.010 |
Why?
| | DNA | 1 | 2006 | 1404 | 0.010 |
Why?
| | United States | 1 | 2016 | 13871 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2016 | 14522 | 0.010 |
Why?
| | Genotype | 1 | 2003 | 1833 | 0.010 |
Why?
| | Child, Preschool | 1 | 2010 | 10490 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2006 | 5756 | 0.010 |
Why?
| | Pregnancy | 1 | 2006 | 6417 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2006 | 2006 | 0.010 |
Why?
|
|
Kaplan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|